Carregant...
Sexual problems during the first two years of adjuvant treatment with aromatase inhibitors
INTRODUCTION: Sexual dysfunction has only recently been recognized as a highly prevalent side effect of adjuvant aromatase inhibitor (AI) therapy for breast cancer. AIMS: A cross-sectional survey using standardized measures of female sexual function was designed to provide a detailed view of sexual...
Guardat en:
| Publicat a: | J Sex Med |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4370340/ https://ncbi.nlm.nih.gov/pubmed/25141792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jsm.12684 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|